Council for europe portal
Language : en Search
Choose language

NEW DATES: WORKSHOP WEBINARS on ‘Quality Control of Veterinary Vaccines’

09 March 2021 to 10 March 2021
Strasbourg, France

Joint EDQM EPAA JRC Webinar Sessions on Quality Control of Veterinary Vaccines


Since the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes opened for signature in 1986, the European Pharmacopoeia Commission and its experts have made significant progress in Replacing, Reducing and Refining (3Rs) the use of animals in tests for the development and control of medicinal products. 

The EDQM, in collaboration with the EPAA and JRC, is organising a virtual workshop (webinar sessions) entitled ‘Novel in vitro model as alternative to in vivo toxoid vaccines testing: Clostridium septicum vaccine as a proof of concept’.


Programme overview

The webinars aim to facilitate the implementation of the new in vitro cell-based assays for in-process quality control, validated through collaborative study BSP130 - a joint EDQM-EPAA project successfully completed in 2018. The webinars will provide a forum to discuss study results and share practical experience and knowledge of these new methods with BSP130 study participants, control laboratories, regulators and other relevant stakeholders. to take place on 9 and 10 March 2021.

Also on the agenda for discussion will be the regulatory consequences of the revisions to veterinary vaccine monographs undertaken by the European Pharmacopoeia Group of Experts on Veterinary vaccines and sera (15V) and the potential for international harmonisation.

Participants will have the opportunity to interact directly with specialists in the field, discuss specific technicalities based on case studies and share practical experience using concrete examples.

The final programme can be found HERE.

  • Workshop Webinar 1: 9 March, 13:00-18:00 (CET, Paris, France)

This opening webinar will give an overview of the activities of the EDQM, the EPAA and the JRC EURL ECVAM in the field of 3Rs. There will also be presentations on the study aims and results of the Clostridium Vaccine Project (BSP130) as well as the outcome of a field survey carried out on Clostridium Vaccines Control.


  • Webinar 2: 10 March, 13:30-18:00 (CET, Paris, France)

The second part of the workshop will focus on the proposals being made for European Pharmacopoeia monographs, as well as feedback from industry and regulators. This will be followed by presentations considering the potential application of the Approach to other Toxoid Vaccines. The session will try to summarise the workshop discussions and there will be a Q&A Session allowing participant’s time to ask their individual questions.


Who should attend?

This virtual workshop (webinar sessions) will be of particular interest to those working in vaccine manufacture and/or involved in the control and licencing of vaccines for veterinary use.


System requirements

No special software is necessary for the webinar. If you wish to connect to audio using VoIP (Voice over Internet Protocol) you will need a fast Internet connection, a microphone and speakers. A USB headset is recommended. The VoIP connection is free.

You are strongly advised to consult your IT Department to ensure your computer can receive the webinar and that the following domain names are neither rejected nor blocked as spam, otherwise you will not receive the link to connect to the webinar: and



EPAA is a Public-Private Partnership across seven industry sectors and between European Commission and Industry stakeholders. Launched in 2005, it gathers 37 companies, 8 European trade federations and 5 Directorates-General of the European Commission.
Further information is available here.

EURL ECVAM is an integral part of the Joint Research Centre (JRC, Ispra, Italy), the science and knowledge service of the European Commission. Its mandate, as specified in Directive 2010/63/EU, is linked to the advancement of the Replacement, Reduction and Refinement (the Three Rs) of animal procedures. Current activities cover research and collaboration with research initiatives, validation studies, dissemination of information, knowledge sharing, promotion of alternative methods in an international context across disciplines and sectors. Further information is available here.



twitter facebook googleplus pinterest linkedin email